ES2172504T3 - Ensayo diagnostico para la enfermedad de lyme. - Google Patents

Ensayo diagnostico para la enfermedad de lyme.

Info

Publication number
ES2172504T3
ES2172504T3 ES91920633T ES91920633T ES2172504T3 ES 2172504 T3 ES2172504 T3 ES 2172504T3 ES 91920633 T ES91920633 T ES 91920633T ES 91920633 T ES91920633 T ES 91920633T ES 2172504 T3 ES2172504 T3 ES 2172504T3
Authority
ES
Spain
Prior art keywords
patient
borrelia burgdorferi
viable
kit
aliquot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920633T
Other languages
English (en)
Inventor
Steven M Callister
Ronald F Schell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUNDERSEN MEDICAL FOUNDATION
Original Assignee
GUNDERSEN MEDICAL FOUNDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUNDERSEN MEDICAL FOUNDATION filed Critical GUNDERSEN MEDICAL FOUNDATION
Application granted granted Critical
Publication of ES2172504T3 publication Critical patent/ES2172504T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Packages (AREA)

Abstract

SE PRESENTA UN METODO PARA DETERMINAR UNA PRUEBA PARA DETERMINAR CUANDO UN PACIENTE HA SIDO EXPUESTO O INFECTADO POR LA "BORRELIA BURGDORFERI" QUE COMPRENDE LA RECOGIDA DE SUERO DEL PACIENTE; LA PREPARACION DE UNA MEZCLA DE UNA MUESTRA QUE COMPRENDA UNA PARTE DEL SUERO DEL PACIENTE Y UNA INOCULACION DE ORGANISMOS "BORRELIA BURGDORFERI" VIABLES. LA INCUBACION DE LA MEZCLA DE LA MUESTRA; LA DETERMINACION DEL NUMERO DE ORGANISMOS VIABLES QUE PERMANECEN EN LA MEZCLA DE LA MUESTRA DESPUES DE LA INCUBACION; Y LA COMPARACION DEL NUMERO CON LA CANTIDAD DE ORGANISMOS VIABLES QUE QUEDAN EN UN CONTROL. TAMBIEN SE PRESENTA UN EQUIPO DE ENSAYO QUE ES UTIL PARA DETERMINAR UN PACIENTE HA SIDO EXPUESTO O INFECTADO POR LA "BORRELIA BURGDORFERI". EL EQUIPO CONTIENE LOS REAGENTES NECESARIOS PARA PRACTICAR EL METODO DE PRUEBA PRESENTADO. EN UNA FORMA MAS AMPLIA, EL EQUIPO COMPRENDE UN INOCULADOR DE ORGANISMOS VIABLES DE "BORRELIA BURGDORFERI". EL EQUIPO TAMBIEN PUEDE CONTENER UNA PARTE ALICUOTA DE SUERO NORMAL, UNA PARTE ALICUOTA DE UN MEDIO BSK Y/O UNA PARTE ALICUOTA DEL COMPLEMENTO. TAMBIEN PUEDEN INCLUIRSE EN EL EQUIPO REAGENTES, TUBOS Y OTROS MATERIALES.
ES91920633T 1990-10-31 1991-10-31 Ensayo diagnostico para la enfermedad de lyme. Expired - Lifetime ES2172504T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60579890A 1990-10-31 1990-10-31

Publications (1)

Publication Number Publication Date
ES2172504T3 true ES2172504T3 (es) 2002-10-01

Family

ID=24425261

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920633T Expired - Lifetime ES2172504T3 (es) 1990-10-31 1991-10-31 Ensayo diagnostico para la enfermedad de lyme.

Country Status (11)

Country Link
EP (1) EP0556281B1 (es)
JP (1) JP2683156B2 (es)
AT (1) ATE213066T1 (es)
AU (2) AU665934B2 (es)
CA (1) CA2095235C (es)
DE (1) DE69132926T2 (es)
DK (1) DK0556281T3 (es)
ES (1) ES2172504T3 (es)
FI (1) FI104328B1 (es)
NO (1) NO315764B1 (es)
WO (1) WO1992008135A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010207124A (ja) * 2009-03-09 2010-09-24 Ihi Corp 原料供給システム、プラント

Also Published As

Publication number Publication date
NO315764B1 (no) 2003-10-20
NO931569D0 (no) 1993-04-29
FI104328B (fi) 1999-12-31
CA2095235A1 (en) 1992-05-01
AU8930291A (en) 1992-05-26
CA2095235C (en) 2007-06-05
WO1992008135A1 (en) 1992-05-14
DK0556281T3 (da) 2002-03-18
FI931932A0 (fi) 1993-04-29
JP2683156B2 (ja) 1997-11-26
EP0556281B1 (en) 2002-02-06
FI931932A (fi) 1993-04-29
FI104328B1 (fi) 1999-12-31
ATE213066T1 (de) 2002-02-15
DE69132926D1 (de) 2002-03-21
NO931569L (no) 1993-06-30
DE69132926T2 (de) 2002-09-26
AU665934B2 (en) 1996-01-25
JPH06510900A (ja) 1994-12-08
AU4221496A (en) 1996-04-18
EP0556281A1 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
Thomason et al. Proline aminopeptidase activity as a rapid diagnostic test to confirm bacterial vaginosis
CA1227131A (en) Diagnostic test for streptococcus a
CA2121361A1 (en) Apparatus and Method of Saliva Collection and Verification for Dried Saliva Spot Drug and HIV Antibody Testing
Morgan et al. Evaluation of an enzyme-linked immunosorbent assay for the detection of herpes simplex virus antigen
CA1321045C (en) Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor
Gerencser et al. Serological identification of Actinomyces using fluorescent antibody techniques
Altaie et al. Comparison of two commercially available enzyme immunoassays for detection of Clostridium difficile in stool specimens
ES2172504T3 (es) Ensayo diagnostico para la enfermedad de lyme.
EP0402993A3 (en) Diagnostic test kit and method for determination of chlamydial antigen using a membrane having surface hydroxy groups
US4741999A (en) Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
Leland et al. Evaluation of the L-CLONE Legionella pneumophila serogroup 1 urine antigen latex test
Abshire et al. The use of fluorescent antibody techniques for detection of Streptococcus faecalis as an indicator of fecal pollution of water
Perine et al. New technologies for use in the surveillance and control of yaws
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
RU2285263C1 (ru) Способ диагностики туберкулеза
AU602881B2 (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
ATE173543T1 (de) Verfahren zum nachweis einer cmv-infektion
JPH0611509A (ja) バクテロイデス微生物の測定のための直接バインディングアッセイ
EP0154916A2 (en) Enzyme/immunofluorescent assay for anti-treponemal antibodies
Birry et al. Further evaluation of an automated fluorescent treponemal antibody test for syphilis
Jensen Evaluation of Two Commercial Kits for Rapid Detection of Human Rotavirus in Feces: Rotalex®, A Latex Agglutination Test and Rotavirus Elisa Kit®
Brown Fluorescent antibody techniques for the diagnosis of enteric infections
Manthorpe et al. Anti-Dna Antibody Determination in Systemic Lupus Erythematosus (Sle): Predictive Value as Compared with the LE-Cell Test
Collins Diagnosing Viral Infections: Beyond The Paired Sera

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 556281

Country of ref document: ES